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In contrast to the limited use of functional magnetic resonance imaging (fMRI) in clinical diagnostics, it is cur-
rently a mainstay of neuroimaging in clinical and basic brain research. However, its non-invasive use in combi-
nationwith its high temporal and spatial resolutionwouldmake fMRI a perfect diagnostic tool.We are interested
in whether a pharmacological challenge imposed on the brain can be reliably traced by the blood oxygen level-
dependent (BOLD) signal and possibly further exploited for diagnostics. We have chosen a systemic challenge
with lactate and pyruvate to test whether the physiological formation of thesemonocarboxylic acids contributes
to the BOLD signal and can be detected using fMRI. This information is also of interest because lactate levels in the
cerebrospinal ﬂuid rise concomitantly with reduced vascular responsiveness of the brain during the progression
of Alzheimer disease (AD). We studied the BOLD response after a low-dose lactate challenge and monitored the
induced plasma lactate levels in anesthetized non-human primates. We observed reliable lactate-induced BOLD
responses, which could be conﬁrmed at population and individual level by their strong correlationwith systemic
lactate concentrations. Comparable BOLD effects where observed after a slow infusion of pyruvate. We show
here that physiological changes in lactate and pyruvate levels are indeed reﬂected in the BOLD signal, and de-
scribe the technical prerequisites to reliably trace a lactate challenge using BOLD-fMRI.
1. Introduction
Functional magnetic resonance imaging (fMRI) is one of the
most frequently used neuroimaging techniques for basic and clinical
brain research in humans, and is used surprisingly less often for
clinical diagnostics (Jezzard and Buxton, 2006). The systematic im-
plementation of fMRI in diagnostics would evidently require exten-
sive preliminary investigations of the degree to which fMRI may be
sensitive to changes in the concentrations of various metabolites or
neurotransmitters that are often induced by neurodegenerative dis-
orders. For example, lactate exhibits a prominent role in brain me-
tabolism (Fox and Raichle, 1986; Pellerin and Magistretti, 2004).
Transient neuronal activation can apparently trigger glycolysis,
resulting in elevated lactate levels (Prichard et al., 1991; Hu and
Wilson, 1997). Lactate and pyruvate can then be funneled into the
tricarboxylic acid cycle to provide neurons with energy (Pellerin
and Magistretti, 2004). The apparent use of the glycolytic pathway
was demonstrated by an increase in cerebral blood ﬂow (CBF),
and the metabolic rate of glucose which was accompanied by only
a slight increase in the metabolic rate of oxygen (Fox and Raichle,
1986; Fox et al., 1988). The coupling of the CBF response to the
NADH/NAD+ ratio which is in near equilibrium with the lactate/
pyruvate ratio was then shown by Mintun et al. (2004; Vlassenko
et al., 2006). Given the importance of lactate in the context of physio-
logical brain metabolism, changes in lactate levels are to be expected
under pathological circumstances. For example, elevated lactate levels
in the cerebrospinal ﬂuid of patients suffering from Alzheimer disease
(AD) have already been observed (Redjems-Bennani et al., 1998).
Such changes reﬂect abnormalities in the regulation of cerebral metab-
olism and potentially neurovascular coupling, which in turn could have
diverse effects on the fMRI signal (Reiman et al., 2001; Iadecola, 2004;
Reiman et al., 2004, 2005). However, before one can investigate how
these abnormalities affect the blood oxygen level-dependent (BOLD)
signal, we should focus on the question of how the physiological forma-
tion of lactate contributes to the BOLD signal.
We set out to study fMRI responses in the monkey brain after
moderate increases of systemic lactate concentration. To do so, we
used direct systemic application to mimic the physiological formation
of lactate and measured BOLD contrast in the early visual cortex of
⁎ Corresponding author. Fax: +49 7071 601 658.
E-mail address: arauch@tuebingen.mpg.de (A. Rauch).
1 Equal contribution.


Published in 1HXUR,PDJH±
which should be cited to refer to this work.
ht
tp
://
do
c.
re
ro
.c
h
anesthetized macaques, while using microdialysis (venous catheter)
to monitor blood lactate concentration. To best simulate the physio-
logical formation of lactate in the brain, we increased plasma lactate
levels moderately and continuously over the course of minutes,
with overall increments in blood lactate concentration corresponding
to light physical exercise (Freund et al., 1990). We present evidence
that such moderate changes in blood lactate concentration are indeed
detectable using BOLD fMRI, and are accompanied by moderate in-
creases in neuronal activity. This ﬁnding suggests that, at least in
principle, changes in lactate levels due to physiological, age-related,
or pathological metabolic adaptations, such as those reported in neu-
rodegenerative disorders, can be assessed using noninvasive BOLD-
fMRI methodology.
2. Materials and methods
For this study, we used ten anesthetized rhesus monkeys (Macaca
mulatta, 7 male and 3 female, age range 4 to 11 years, weighing 4.6 to
12.5 kg). The experimental procedures were approved by the local au-
thorities (Regierungspraesidium) and are in agreement with guidelines
of the European Community for the care of laboratory animals. Proce-
dures have previously been described in detail (Logothetis et al.,
1999). All vital parameters were monitored during anesthesia. After se-
dation of the animals using ketamine (15 mg/kg), anesthesiawas initiat-
ed with fentanyl (31 μg/kg), thiopental (5 mg/kg), and succinylcholine
chloride (3 mg/kg), and then the animalswere intubated and ventilated.
A Servo Ventilator 900C (Siemens, Germany) was used for ventilation,
with respiration parameters adjusted to each animal's age and weight.
Anesthesia was maintained using remifentanil (0.2–1 μg/kg/min) and
mivacurium chloride (4–7 mg/kg/h). An iso-osmotic solution (Jonos-
teril, Fresenius Kabi, Germany) was infused at a rate of 10 ml/kg/h. Dur-
ing the entire experiment, each animal's body temperature was
maintained between 38.5 °C and 39.5 °C, and SpO2 was maintained
above 95%.
Every test subject received the same amount of lactate per minute
adjusted to its individual body weight (0.04 mmol/kg/min) to ensure
the comparability of any lactate-induced effects. The individual dose
was adjusted by adapting lactate concentration and the infusion
ﬂow rate to each individual test subject. The lactate concentrations
used ranged from 0.15 M to 0.6 M (pH, 7.2–7.35) and the ﬂow rates
ranged from 0.8 ml/min to 2.5 ml/min, resulting in an infusion time
of 12 min to 20 min. Lactate solution was applied to the continuous
infusion of Jonosteril electrolyte solution (10 ml/kg/h) to dilute lac-
tate to the above-mentioned concentrations. This application proto-
col also ensured that any pH changes stayed within a small range.
We explicitly did not use a bolus injection because we wanted to
mimic a physiological lactate increase comparable to lactate increases
during moderate physical exercise (Freund et al., 1990). We applied
the same volume of phosphate-buffered saline in ﬁve experimental
sessions for control experiments (131.5 mM sodium chloride,
10 mM disodium hydrogen phosphate, 2.5 mM monosodium phos-
phate; pH=7.2). Furthermore, we applied 0.04 mmol/kg/min of py-
ruvate in eight experimental sessions. Lactate was applied using a
custom-made, pressure-operated pump that used high-precision
ﬂow meters to control ﬂow and volume (Sensirion, Switzerland), in
combination with Matlab functions to provide an online readout
(The MathWorks, Natick, MA, USA). All chemicals were purchased
from Sigma-Aldrich (Schnelldorf, Germany).
MR images were acquired using a vertical 4.7 T Bruker BioSpec
scanner with an inner bore diameter of 40 cm and a 7 T Bruker
BioSpec scanner with an inner bore diameter of 60 cm (Bruker
BioSpin, Ettlingen, Germany). We performed three experiments
at 4.7 T (lactate), 40 experiments at 7 T (27 lactate, ﬁve saline,
eight pyruvate) and ﬁve cerebral blood ﬂow (CBF) experiments at
7 T (lactate). At 4.7 T, we used a custom-built phased array
(Goense et al., 2010) in combination with a linear transmit-coil
and eight-shot gradient echo planar imaging (EPI) with a ﬁeld of
view (FOV)=64×48 mm, matrix=128×96, 7 slices (slice thick-
ness=1 mm), echo time/repetition time (TE/TR)=20/500 ms,
and ﬂip angle (FA)=40°. At 7 T, we used a custom-made quadra-
ture volume coil (Augath et al., in preparation) and an eight-shot
gradient echo EPI, FOV=96×96 mm, matrix=128×128, 13 slices
(slice thickness=2 mm), TE/TR=20/750, and FA=47.6°. To fur-
ther improve efﬁciency at 7 T, we also used a single-shot gradient
EPI, with FOV=72×72 mm, matrix=96×96, 11 slices (slice thick-
ness=2 mm), TE/TR=20/3000, and FA=90°. For the six function-
al CBF measurements at 7 T, we used a volume coil to transmit in
combination with a custom-built, 4-channel phased array
(Goense et al., 2010). Perfusion imaging was performed using
ﬂow-sensitive alternating inversion recovery (FAIR; Kim, 1995)
for arterial spin labeling, with alternating slab-selective and non-
selective inversion pulses (13–15 ms hyperbolic secant pulse).
Inversion time was 1300 ms, slab 6 mm, FOV=64×48 mm, resolu-
tion=1×1 mm, slice thickness=3 mm, receiver BW=150 kHz, a
shortest possible TE=6 to 7 ms, TR=3000 ms, and FA=90°.
Visual stimuli were presented using a ﬁber optic system (Avotec,
Silent Vision, USA). To adjust the plane of focus, contact lenses
(hard PMMA lenses, Wöhlk, Kiel, Germany) were inserted to the
monkey's eyes. The stimulus was presented in a block design that
showed a full ﬁeld rotating polar checkerboard for 48 s (ON period),
followed by an isoluminant blank screen for the same duration (OFF
period). The direction of rotation was reversed every 8 s to avoid
adaptation.
We used low-ﬂow microdialysis for systemic lactate sampling in
8 experiments. Lactate concentrations were analyzed using hydro-
philic liquid interaction chromatography coupled to electro-spray
ionization mass spectrometry (Li et al., 2011). We sampled from a su-
perﬁcial large leg vein using a microdialysis catheter CMA 64, 20-mm
PAES membrane, 0.6 mm o.d., 20 kDa cut-off (CMA Microdialysis AB,
Sweden). We allowed the semi-permeable membrane to stabilize
for 1 h, then sampling was initiated with a ﬂow rate of 2 μl/min. We
used a refrigerated fraction collector CMA 740 (CMA Microdialysis
AB, Sweden) in which the samples were stored at 6 °C. The temporal
resolution of the sampling process was 3 min. After the experiment,
the samples were diluted with a solution of 80% acetonitrile contain-
ing 0.1% formic acid, and then centrifuged for 3 min (4000 rpm at
4 °C). 3-
13
C-Lactate (
13
C-Lac) was used as internal standard for lactate.
The mass spectrometer was operated in multiple-reaction monitoring
(MRM)mode for quantitative analysis. Lactate and
13
C-Lac were mon-
itored based on transfers of m/z 89→89, and m/z 90→90, respec-
tively. The detection limit of lactate was 0.9 pmol (for a 6-μl in vivo
sample).
We applied lactate and pyruvate to two monkeys in nine elec-
trophysiology experiments. These two monkeys had miniaturized
chambers implanted over V1 and were used for invasive recordings.
We used NeuroNexus probes (NeuroNexus Technologies, Ann
Arbor, USA) of 150 μm thickness and 3 mm long shank with 16
electrode sites with 50 μm site spacing and 413 μm2 electrode
sites. The impedance of the electrodes was in the range of
700 kΩ. The preampliﬁers for the electrophysiological recordings
were custom-made. The signals were ampliﬁed and ﬁltered into a
band of 1–8 kHz (Alpha-Omega Engineering, Nazareth, Israel) and
then digitized at 20.833 kHz with 16-bit resolution (National In-
struments, Austin, TX), ensuring enough resolution for both local
ﬁeld and spiking activities. The analog-to-digital converter was
linked directly to a PC running a real-time QNX operating system,
where the signal was stored.
2.1. Data analysis
Our region of interest (ROI) consisted of the early visual cortex
(V1 and V2). A short scan (12 min) preceding the injection scan
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was used to identify voxels within the ROI that showed reliable
visually-induced modulation. We used a boxcar convolved with a he-
modynamic response function (gamma variate function) as a regres-
sor to detect visually-induced modulation. The correlation coefﬁcient
of every voxel with this regressor was calculated. Voxels demon-
strating robust visually-induced modulation (Pb0.02) were consid-
ered for further analysis. The voxels identiﬁed by the short
preceding scan were then monitored during the long (40 min) injec-
tion scan and studied for lactate-induced effects. This approach
allowed us to investigate lactate-induced effects without making
any a priori assumptions regarding the potentially induced BOLD re-
sponse. The same approach was used for the CBF measurements, for
which voxels were selected according their visually-induced modu-
lation during the short scan preceding the injection scan. The time
course of CBF changes was obtained with linear surround subtraction
(Wong et al., 1997). We acquired BOLD fMRI data in 35 sessions dur-
ing lactate injections. Five of these scans were discarded: two be-
cause of a defect in the infusion pump, two because of artifacts
caused by a shift in the monkey's position, and one because of a
lack of visually-induced modulation. Additionally, one of the six
functional CBF measurements was discarded because of a positioning
artifact. The remaining 30 BOLD fMRI and ﬁve CBF voxel time courses
were linearly detrended and then normalized. The single traces were
normalized so that the mean amplitude of the stimulus-induced
modulation before lactate injection corresponded to one. Every
trace was tested for lactate-induced changes in the visually-
induced modulation and the baseline. Visually-induced modulation
was calculated by subtracting the OFF periods from the ON periods
in the averaged voxel time course of our ROI. The baseline shifts in
the BOLD signal were analyzed by calculating the mean values of
the ON and OFF periods. The threshold for changes in modulation
and baseline was set at P>0.05. This threshold had to be crossed
for at least 6.4 min (the duration of the pre-injection period). We de-
termined four variables that deﬁned the effect: the maximal percent-
age change, the start of the change (when modulation or baseline
crossed the threshold), the time of the maximal effect, and the end
of the effect (the last point above the threshold). For statistical anal-
ysis, a time window of 6.4 min around the maximum change was se-
lected (range, 19.2–25.6 min) and the modulation and respective
baseline during this window was compared with the pre-injection
period (range, 0–6.4 min) with a two-tailed t-test (alpha=0.05).
Additionally, two other time windows before (range, 6.5–12.8 min)
and after (range, 28.9−35.3 min) the maximum change were de-
ﬁned for further comparison. The plasma lactate levels were also
compared using two-tailed t-tests (alpha=0.05) during these differ-
ent time windows. The time windows were adapted to match even
numbers of scanned volumes, which explains the odd time stamps
of the selected windows. Analysis was performed using custom writ-
ten code based on Matlab.
To analyze the electrophysiological data, we used a one-second
window to calculate the power spectral density of two bands:
24–90 Hz LfpH (high local ﬁeld potential) and 800–3000 Hz multi-
unit activity MUA (multiunit activity, Rauch et al., 2008). We did
not consider layer-speciﬁc effects, and averaged the obtained PSD
trace over all 16 channels. Next, we calculated changes in modula-
tion and baseline. Visually-induced modulation was calculated by
subtracting the OFF periods from the ON periods in the averaged
PSD trace. The baseline shifts were analyzed by calculating the
mean values of the ON and OFF periods. From these traces, we
extracted the maximal percentage change, the start of the change
(when modulation or baseline crossed the threshold), the time of
the maximal effect, and the end of the effect (the ﬁnal point
above the threshold). In addition, we performed two-tailed t-tests
using the same time windows as were used for the BOLD analysis
in the single experiments (averaged over 16 channels), as well as
in the average of the six experiments.
3. Results
We applied lactate systemically in eight monkeys, with a total of
30 fMRI scans. We used systemic lactate concentrations comparable
to those produced by moderate physical exercise (Freund et al.,
1990). The concentrations were adapted such that all monkeys re-
ceived an identical amount of lactate per minute according to individ-
ual body weight (see Methods).
Fig. 1 depicts the effects on the BOLD signal after a lactate infusion,
and the corresponding plasma lactate concentrations for a single ex-
periment (J08, an 8-year-old, 10.5-kg, male monkey). Fig. 1A–C
show the distribution of the visually-activated voxels in the early vi-
sual cortex (V1 and V2), while Fig. 1D shows the averaged BOLD
time course across the depicted voxels (gray) and the time course
of the plasma lactate levels (green). We depict the distribution of
the selected voxels for the three central slices in V1 and V2 with an
in-plane resolution of 0.75×0.75 mm and 2-mm inter-slice distance;
the depicted voxels are color-coded according to their correlation
with the visual stimulation paradigm. Lactate application started
after the fourth ON–OFF period (6.4 min) and lasted 14 min (gray
shading). First, a reliable, visually-induced modulation was observed
throughout the entire experimental period, and was not signiﬁcantly
affected by lactate. Second, we induced a positive baseline shift in the
BOLD response after the systemic application of lactate. The positive
shift in the BOLD response was tightly correlated with the monitored
increase of plasma lactate, which reached its peak at 24 min of total
scan time. Plasma lactate levels reached 3.4 mM (which is compara-
ble to serum lactate levels observed during moderate physical exer-
cise; Freund et al., 1990), starting from levels slightly above 2 mM
before infusion.
To test for the consistency of the observed effects on BOLD
response and plasma lactate levels, we performed a group analysis
of all 30 experiments. Our population of test animals consisted of 1
female and 7 male monkeys (J08, E04, I02, I08, A09, C06, K07, J07)
with an age range from 4 to 11 years, weighing between 4.6 and
12.5 kg, provided with identical housing and comparable food supply.
In Fig. 2A, the averaged time courses of the BOLD response across all
30 experiments are depicted with the onset of systemic lactate appli-
cation after the fourth ON–OFF period. The time windows were
selected to match even numbers of acquired volumes and are of iden-
tical size. During the pre-infusion period (blue) we observed a reli-
able, visually-induced modulation of 2.8±1.1%. As in the single
experiment depicted in Fig. 1, we observed a positive baseline shift
in BOLD signal that peaked within a time window of 19.2 to
25.6 min (red). The positive baseline shift resulted in an increase of
0.6±0.2% of the mean BOLD signal compared with pre-infusion
(blue), which corresponds to 22.1±7.4% of the visually-induced
modulation (2.8±1.1% of the signal). This baseline shift was signiﬁ-
cant in 26 of the 30 experiments (Pb0.05); no reliable effect was ob-
served in the remaining four experiments. The lactate-induced BOLD
response lasted up to 27.8 min of the total scan time, and then recov-
ered so that no changes were detectable in the time window from
28.9 to 35.3 min (gray). In the time window just after the start of lac-
tate application (from 6.5 to 12.8 min of total scan time; green), no
apparent changes in BOLD response were observed, and plasma lac-
tate remained at pre-infusion levels. This ﬁnding is most likely due
to our slow infusion protocol and the capacity of erythrocytes to buff-
er lactate to a certain degree, mitigating sudden increases (Smith et
al., 1997).
In Fig. 2B, we compared the mean plasma lactate levels across
eight experiments (blue trace) with the mean baseline shift over all
30 experiments (red trace). Four male monkeys (J08, C06, K07, J07;
age range 6 to 9 years; weight range 5 to 11.5 kg) were used to mon-
itor plasma lactate levels. The induced effects were compared for the
identical time window as is depicted in Fig. 2A. We observed signiﬁ-
cant plasma lactate increases in all eight experiments (Pb0.05). In
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the red time window (19.2 to 25.6 min), plasma lactate levels
reached a mean maximum of 2.5±0.9 mM, starting from a mean
baseline concentration of 1.1±0.5 mM (blue time window, 6.5 to
12.8 min). Maximum plasma lactate was reached at 22.9±4.8 min
of total scan time. Compared with lactate levels, BOLD response
reached its maximum after 23.4±8 min of total scan time, which
we consider a very reliable match considering the different tempo-
ral resolutions of the fMRI and the sampling method. Reliability is
also indicated by the high correlation between the plasma lactate
time course and the BOLD response at an individual level (coefﬁ-
cients of correlation: 0.60 for J08, 0.52 for C06, 0.69 for K07, and
0.85 for J07).
To estimate the distribution of the observed effects on BOLD re-
sponse within the studied population, we extracted the timing and
the peak of the lactate-induced baseline shift, and compared them
to each other in a scatter plot (Fig. 3A). The amplitude of the BOLD re-
sponse was extracted as a percentage of the overall visually-induced
modulation (see above). In every test subject, lactate induced a posi-
tive baseline shift in the BOLD signal, although the amplitude varied
from 16% in the weakest responder to 39% in the strongest responder.
The onset of the BOLD baseline increases began between 7.6 min
(onset effect, early responder) and 19.8 min (onset effect, late
responder), with a mean onset of 16.9±7.5 min. The actual BOLD
response lasted for a period of 5.6 to 27.6 min (short versus long
pharmacokinetics), with a mean duration of 11.0±8.5 min. Differ-
ences in the lactate-induced BOLD response are also reﬂected in the
actual plasma lactate levels (Fig. 3B). We extracted the individual lac-
tate levels before and after infusion and the timing of the peak con-
centration. The lactate levels ranged from 0.3 to 2.1 mM before
infusion and reached maximum levels between 2.0 and 4.0 mM. The
onset of plasma lactate increases began between 10.1 (early responder)
and 20.6 min (late responder), with a mean onset of 14.1±4.5 min.
Lactate remained elevated for a duration of 12 to 21 min (short versus
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Fig. 1. Example experiment functional magnetic resonance imaging (fMRI) and systemic lactate application: Panels A–C depict the distribution of voxels that are signiﬁcantly cor-
related with the stimulus (eight-shot GE-EPI overlaid on an anatomical scan (FLASH), acquired at 7 T, slices 7 through 9, 0.75×0.75 mm resolution, and 2-mm inter-slice distance).
The correlation coefﬁcient with the regressor is color-coded. The gray trace in panel D depicts the mean time course of the above voxels during the scan with lactate infusion. The
infusion began after the fourth stimulus repetition and lasted for 14 min (gray shading). The red dashed lines delineate the amplitude of stimulus-induced modulation during the
pre-injection period. Image intensity has been normalized so that the modulation of the pre-injection period corresponds to one. The green trace shows the plasma lactate levels of
the same monkey in a separate experiment using the same infusion protocol as was used for the fMRI experiment.
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Fig. 2. (A) Mean time course over 30 functional magnetic resonance imaging (fMRI)
sessions; the lactate infusion started after the fourth stimulus repetition (6.4 min)
and lasted for a mean duration of 18 min (black dashed lines). Shading indicates the
time windows used for statistical analysis: blue, before injection (0–6.4 min); green,
during injection (6.5–12.8 min); red, shortly after injection (19.2–25.6 min); and
gray, recovery phase (27.2–33.6 min). (B) The mean plasma lactate concentration
over 8 experiments (blue) and the mean baseline change over 30 fMRI experiments
(blood oxygen level-dependent signal, red); lactate injection started after 6.4 min
and lasted for a mean duration of 18 min.
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long pharmacokinetics), with a mean duration of 18.4±7.4 min.
Lactate infusion is indicated by gray shading, and onset timings are
provided in relation to total scan time (Fig. 3A, B). Taken together,
and also taking into account the variability within the studied popu-
lation and irrespective of differences in temporal resolution be-
tween the methods used, the BOLD response and the actual plasma
lactate levels correlated to a high degree. The variability observed
in the timing and amplitude of the lactate-induced effects reﬂects
known differences in lactate turnover that depend on the training
level and metabolic state of the test subject (Oyono-Enguelle et al.,
1990).
We were also interested in whether we could observe reliable vas-
cular effects induced by lactate application, because it has already
been shown that lactate has distinct vasodilatory effects (Reiman et
al., 1989). However, these vascular effects were triggered by relative-
ly high doses of lactate. Therefore, we only expected subtle changes in
CBF using our infusion protocol, which is comparable to a protocol
used by Ido et al. that produced CBF changes only in the range of 4%
(Ido et al., 2004). Fig. 4 depicts the mean of ﬁve CBF measurements
after lactate infusion. We observed reliable visually-induced modula-
tion in the CBF recordings in the range of 19±7% (Zappe et al., 2008),
but did not detect any signiﬁcant baseline shifts comparable to the
changes in the BOLD recordings.
To investigate the neuronal activity underlying the BOLD effect,
we performed six electrophysiological recordings in two monkeys.
During the lactate infusion, we observed an effect in the LfpH
band (24–90 Hz, Fig. 5). Both baseline and stimulus-induced mod-
ulation increased signiﬁcantly in ﬁve of six experiments. Lactate in-
fusion induced a mean baseline increase of 23.0±1.2% and a mean
modulation increase of 76.0±20%; this effect lasted from 12.5±
1.5 min to 32.0±4.3 min. No signiﬁcant effect was observed in
the MUA (400–3000 Hz). We also tested the effect of pyruvate on
the BOLD signal and electrophysiology, because of the dependence
of lactate and pyruvate mediated by lactate dehydrogenase
(Williamson et al., 1967). Here we report the electrophysiology
results, the BOLD effect is described later. The three pyruvate injec-
tions exhibited a comparable effect in the LfpH band (Fig. 6) with a
mean baseline increase of 31.0±7.3%. This effect lasted from 8.5±
2.1 min to the end of the recording. In two cases, we also observed
a signiﬁcant increase in modulation. Also the pyruvate injections
did not show a signiﬁcant effect in the MUA.
As control experiments, we infused buffered saline solution to
ensure that lactate-induced BOLD responses were primarily caused
by lactate itself. We also wanted to test whether the applied volumes
(although relatively small) triggered any cardiovascular responses
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Fig. 3. Inter-individual differences in blood oxygen level-dependent functional mag-
netic resonance imaging (BOLD-fMRI) (A) and plasma lactate concentration (B). For
both datasets, we determined four variables that deﬁned the effect: the maximal
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modulation before the injection (100%). Panel B depicts plasma lactate concentration
before injection, and maximal concentration reached after lactate injection. For both
panels, timing and standard deviation of the effect are plotted on the X-axis.
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Fig. 4. Mean time course of regional cerebral blood ﬂow (CBF) measurements during
lactate infusion (N=5). The red dashed lines delineate the amplitude of stimulus-
induced modulation during the pre-injection period. Gray shading symbolizes the
time of lactate application (13.5 min). Image intensity has been normalized so that
the modulation of the pre-injection period corresponds to one.
Fig. 5. The power spectrum density of the LfpH band (24–90 Hz). Lactate injection
started at 6.4 min and lasted for 12 min (gray shading). The average over the 16 channels
in one representative experiment (A), and the average over all six experiments (B) are
shown. The red dashed lines depict the amplitude of stimulus-inducedmodulation during
the pre-injection period.
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that interfered with the BOLD signal. We used buffered saline
(pH=7.2) for ﬁve applications in three monkeys (Fig. 8). No signiﬁ-
cant changes were observed in the BOLD signal after saline infusion
using the same protocol as was used for lactate infusion (P>0.05).
During pyruvate injection (Fig. 7), we observed a mean baseline in-
crease of 0.9±0.5%, which corresponds to 98.9±63.3% of the
stimulus-induced modulation. This effect exhibited earlier onset
than the lactate effect, lasting from 9.2±2.3 min to 27.5±5.9 min,
with the maximal effect at 17.1±3.1 min.
4. Discussion
Our study results demonstrate that lactate induces a reliably detect-
able BOLD response,with even low lactate doses producing plasma con-
centrations comparable to those brought about by moderate muscular
exercise (Freund et al., 1990). We measured the BOLD response after
a pharmacological challenge by lactate, which we induced by systemic
application in eight anesthetized monkeys. We primarily observed an
increase in the BOLD baseline in visually stimulated early visual cortex,
with little effect on the visually-inducedmodulation. The BOLDbaseline
change correlated directly with the increase in systemic lactate levels.
Moreover, even in this rather heterogeneous group of test subjects,
we could reliably detect lactate-induced changes in the BOLD signal
(this is an important ﬁnding because the differences in physiological
respectively metabolic conditions did not interfere with our measure-
ments). Especially if clinical applications are envisioned in the future,
substantial jitter in the BOLD response must be anticipated precisely
because of the above-mentioned physiological differences between
individuals. Above all, lactate metabolism depends critically on the
training condition and general physiology of human subjects
(Oyono-Enguelle et al., 1990), and this should also hold true for
non-human primates that show an overlap with human physiology
to a very high degree (Voytko and Tinkler, 2004). Indeed, such met-
abolic differences are reﬂected in the different onsets and dynamics
observed after lactate application. However, they were not substan-
tial enough to jeopardize our use of subtle lactate concentrations,
and at an individual level we have shown a high degree of consisten-
cy between BOLD response and plasma lactate levels.
The observed increase in the BOLD response after lactate appli-
cation most likely originates from a combination of neuronal and
vascular effects. Therefore, we also performed electrophysiological
recordings in two monkeys after lactate application, and observed
an increase of neuronal activity in the LfpH band. From previous
studies conducted in our lab, we had already shown that LfpH neu-
ronal activity is a reliable driver of the BOLD signal (Logothetis et
al., 2001; Rauch et al., 2008). Although lactate-induced increases
in neuronal activity have been described in rat hippocampus, the
reason for these increases is yet not fully understood (Bergold et
al., 2009). Furthermore, lactate is known to increase CBF by induc-
ing the production of nitric oxide and other vasodilatory molecules
(Ido et al., 2004; Gordon et al., 2008). However these CBF changes
apparently depend to a certain degree on lactate dose and applica-
tion modality (bolus vs. slow infusion). For example, a bolus injec-
tion that increases systemic lactate to 9.8±2.4 mM has induced a
Fig. 6. The power spectrum density of the LfpH band (24–90 Hz). Pyruvate injection
started at 6.4 min and lasted for 12 min (gray shading). The average over the 16 channels
in one representative experiment (A), and the average over all six experiments (B) are
shown. The red dashed lines depict the amplitude of stimulus-inducedmodulation during
the pre-injection period.
Fig. 7. (A) Mean time course over eight functional magnetic resonance imaging (fMRI)
sessions. The pyruvate infusion started after the fourth stimulus repetition (6.4 min)
and lasted for a mean duration of 18 min (gray shading). (B) The mean baseline change
over 30 fMRI experiments with lactate injection (red), and the mean baseline change
over eight fMRI experiments with pyruvate injection (blue).
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Fig. 8. Control experiment: The mean time course of ﬁve experiments with phosphate-
buffered saline injection. Saline infusion began after the fourth stimulus repetition and
lasted for 12 min (gray shading).
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change in CBF in the range of 38–53% in human visual cortex
(Mintun et al., 2004). This ﬁnding contrasts with the results of a
subtle and continuous application of lactate (2 mmol/kg) in rats
(reaching plasma concentrations of 3.5±0.4 mM), which did not
yield CBF changes greater than 4% (Ido et al., 2004). We veriﬁed
the CBF changes induced by lactate application (low-dose and con-
tinuous infusion) using FAIR recordings, which did not demonstrate
reliable CBF changes. We must consider two possible reasons for
the lack of CBF changes. The ﬁrst reason is most likely the very
low changes in CBF induced by our lactate application protocol,
which would agree with the ﬁndings in rats described by Ido et
al. (2004). The second reason is related to the detection threshold
of the FAIR recordings, which is just within the range of the
expected CBF changes (namely, approximately 5%). Consequently,
the detection threshold was better for the BOLD response (namely,
0.5%) than for the FAIR recordings. Therefore the lactate challenge
described herein (ﬂow 0.04 mmol/kg/min) most likely does not
trigger changes in CBF appreciably greater than 5%. It follows that
although we are reliably able to observe lactate-induced BOLD re-
sponses, a CBF increase in the range of 5% cannot be excluded,
but is not detectable to a statistically signiﬁcant extent in the
same animals. It has been hypothesized that the increase of CBF ob-
served in the work of Mintun et al. (2004) depends on NADH/
NAD+ ratio which is in near equilibrium with the lactate/pyruvate
ratio. Elevated NADH and lactate levels partially trigger the CBF in-
crease, which in turn can be counterbalanced by increasing the
levels of pyruvate and NAD+, respectively (Vlassenko et al.,
2006). However, our systemic application of pyruvate (using a dos-
age identical to the dosage of lactate) did exhibit effects in BOLD
and neuronal responses comparable to lactate. Apparently, in this
low physiological range, lactate and pyruvate may serve as equiva-
lent substrates to induce the BOLD and neuronal effects that we
have observed. The faster BOLD response to pyruvate might be
explained by pyruvate's direct access to the tricarboxylic acid
cycle, while lactate must still be transformed into pyruvate.
The main focus of this study was to test the lower detection
boundaries of lactate-induced BOLD responses to investigate the
impact of the physiological formation of lactate on the BOLD signal.
If the physiological formation of lactate has an impact on the BOLD
signal (which we mimic using our slow infusion protocol), then a
potential diagnostic application could be developed. For example,
the changes in lactate metabolism in neurodegenerative disorders
like AD are gradual and develop over a long period of time. There-
fore, the lack of BOLD responsiveness to a lactate challenge within
the physiological range of lactate formation might be a potential
hallmark of AD. The reduced responsiveness of CBF to sensory stim-
ulation has already been described in AD patients; this reduced CBF
responsiveness also correlated with the severity of AD progression
(Mentis et al., 1998). In agreement with these ﬁndings, Kalman et
al. did not observe a single-photon emission computed tomography
response after a lactate challenge (2.5 mmol/kg) in AD patients in-
duced plasma lactate levels of 5.5±1.226 mM (Kalman et al.,
2005). Reduced responsiveness to physiological lactate formation
in AD is in agreement with a recent review highlighting the close
resemblance of AD to a vascular disorder in which delayed and
weakened responses to increased metabolic demand might be a
preclinical feature (Iadecola, 2004).
Taken together, we demonstrate that physiological lactate forma-
tion can contribute to the BOLD signal, and therefore can be reliably
traced by fMRI. This ﬁnding might be exploited for neurodegenerative
disorders like AD in which lactate metabolism is disturbed (Redjems-
Bennani et al., 1998). Patients at risk of (Richard and Amouyel, 2001)
or in the early stages of AD might potentially exhibit a change of the
BOLD signal in response to physiological lactate formation. Future
clinical studies are needed to demonstrate whether our approach
can deliver such diagnostics.
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